Heidelberg Pharma AG (ETR:HPHA) | WebDisclosure

Basculer en Français

9477	Companies
185475	Keywords
117817	Articles
99317	Press releases

Home
Companies
Heidelberg Pharma AG

BRIEF

published on 04/05/2024 at 09:35, 1 year 8 months ago

Heidelberg Pharma organisera un webinaire R&D pour partager de nouvelles informations sur la recherche sur le cancer

Heidelberg Pharma HDP-101 Myélome Multiple ADC Webinaire R&D
PRESS RELEASE

published on 04/05/2024 at 09:30, 1 year 8 months ago

Heidelberg Pharma to host R&D Webinar following novel data presented at AACR
Heidelberg Pharma AG to host R&D Webinar on 23 April 2024 featuring leading Key Opinion Leaders after presenting novel data at AACR. Event focuses on ADC technologies for cancer treatment

Cancer Treatment Heidelberg Pharma AG R&D Webinar ADC Technologies AACR
BRIEF

published on 03/27/2024 at 09:06, 1 year 8 months ago

Heidelberg Pharma Obtains FDA Orphan Drug Designation for HDP-101 in Multiple Myeloma Treatment

FDA Orphan Drug Designation Heidelberg Pharma HDP-101 Multiple Myeloma
BRIEF

published on 03/27/2024 at 09:06, 1 year 8 months ago

Heidelberg Pharma obtient la désignation de médicament orphelin par la FDA pour le HDP-101 dans le traitement du myélome multiple

FDA Heidelberg Pharma Désignation De Médicament Orphelin HDP-101 Myélome Multiple
PRESS RELEASE

published on 03/27/2024 at 09:01, 1 year 8 months ago

Heidelberg Pharma granted orphan drug designation by FDA for its proprietary ATAC candidate HDP-101
Heidelberg Pharma granted orphan drug designation by FDA for its ATAC candidate HDP-101, targeting multiple myeloma. The designation provides significant benefits for the development and potential marketing of the drug

FDA Orphan Drug Designation Heidelberg Pharma Multiple Myeloma ATAC Candidate
BRIEF

published on 03/25/2024 at 07:15, 1 year 8 months ago

Heidelberg Pharma AG Showcases Robust 2023 Performance and Financial Highlights

Cancer Therapy Financial Results 2023 ADC Technology Heidelberg Pharma AG HDP-101 Trial
BRIEF

published on 03/25/2024 at 07:15, 1 year 8 months ago

Heidelberg Pharma AG présente ses solides performances pour 2023 et ses faits saillants financiers

Résultats Financiers 2023 Technologie CAN Heidelberg Pharma SA Essai HDP-101 Thérapie Contre Le Cancer
PRESS RELEASE

published on 03/25/2024 at 07:10, 1 year 8 months ago

Heidelberg Pharma announces financial figures and reports on successful business performance in 2023
Heidelberg Pharma AG announces financial figures and successful business performance in 2023, including efficacy data from HDP-101 clinical trial. New Management Board team and expansion of ADC technology platform

Financial Results Business Performance HDP-101 ADC Technology Heidelberg Pharma AG
BRIEF

published on 03/19/2024 at 09:52, 1 year 8 months ago

Heidelberg Pharma Receives Upfront Payment from HealthCare Royalty Agreement

Heidelberg Pharma HealthCare Royalty Zircaix Antibody Drug Conjugates Biotech Funding
BRIEF

published on 03/19/2024 at 09:52, 1 year 8 months ago

Heidelberg Pharma reçoit un paiement initial dans le cadre d'un accord de redevances sur les soins de santé

Conjugués Anticorps-médicament Heidelberg Pharma Zircaix Redevance En Matière De Soins De Santé Financement Biotechnologique

Accesswire

Published on 12/05/2025 at 14:00, 58 minutes ago

Ocean Power Technologies Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 14:00, 58 minutes ago

Bonk, Inc. Highlights Major Ecosystem Milestone: Launch of Regulated BONK ETP on SIX Swiss Exchange
Published on 12/05/2025 at 02:35, 12 hours 23 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 12 hours 28 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 13 hours 58 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 14:22, 35 minutes ago

EQS-Adhoc: Jungheinrich AG: Jungheinrich expects to complete sale of its Russian subsidiary in 2026 and adjusts forecast for the 2025 financial year
Published on 12/05/2025 at 14:16, 41 minutes ago

Advanced Blockchain AG: Successful Completion of Token Generation Event of Portfolio company Talisman
Published on 12/05/2025 at 14:10, 47 minutes ago

The Kingdom of Saudi Arabia Launches a New Official Platform, "Saudi Properties", Ahead of the Non-Saudi Property Ownership Law
Published on 12/05/2025 at 13:45, 1 hour 12 minutes ago

BingX Introduces Recurring Buy to Help Users Ride Out Crypto Market Swings
Published on 12/05/2025 at 13:00, 1 hour 58 minutes ago

Zentra Group plc: Posting of Notice of Annual General Meeting

Les Echos

Published on 12/05/2025 at 13:58, 59 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE
Published on 12/05/2025 at 08:45, 6 hours 13 minutes ago

Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 6 hours 13 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/05/2025 at 08:42, 6 hours 15 minutes ago

ENGIE - déclaration mensuelle du nombre total d'actions et de droits de vote composant le capital au 30 novembre 2025
Published on 12/04/2025 at 18:14, 20 hours 43 minutes ago

Résiliation d'une convention conclue entre actionnaires

View all LES ECHOS COMFI WIRE